Nichole Snow, APRN
Adult Health · Spartanburg, SCNPI 1538239587
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 40 manufacturers reported payments, led by Atricure, Inc. at 45.3% of the total. Reporting peaked in 2023 at $5,596 and has fallen 75.6% since, to $1,367 in 2025. Among adult health clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 253 payments — averaging $39.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$5K
- AstraZeneca$966
- Johnson & Johnson$662
- Amgen$476
- Novo Nordisk$339
- Boehringer Ingelheim$309
- plus $3K from 34 others
What the payments were for
- Consulting fees$4,00040%
- Travel & lodging$971%
- Food & beverage$5,89758%
- Education$901%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 12 | $4,564 |
| AstraZeneca | 37 | $966 |
| Johnson & Johnson | 22 | $662 |
| Amgen | 19 | $476 |
| Novo Nordisk | 27 | $339 |
| Boehringer Ingelheim | 7 | $309 |
| Dexcom, Inc. | 12 | $289 |
| Lilly USA, LLC | 16 | $271 |
| Abiomed | 6 | $238 |
| Boston Scientific | 10 | $210 |
| AbbVie | 9 | $209 |
| Novartis | 9 | $200 |
| Pfizer | 12 | $199 |
| Bayer | 11 | $188 |
| Merck | 3 | $113 |
| Abbott | 3 | $103 |
| GSK | 4 | $75 |
| Eisai Inc. | 2 | $58 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
| Chiesi USA, Inc. | 3 | $45 |
| Scpharmaceuticals Inc. | 3 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Medtronic | 1 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $34 |
| Exact Sciences | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Inari Medical, Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Impulse Dynamics (USA) Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$4,000
- XARELTO$243
- Repatha$225
- FARXIGA$207
- JARDIANCE$125
- SYNERGY ABLATION SYSTEM$121
How this compares
$10,084 in reported general payments places this provider in the 95th percentile of 292 adult health providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 516 | $414,839 |
| EntrestoSacubitril/Valsartan | 240 | $202,634 |
| XareltoRivaroxaban | 195 | $159,362 |
| JardianceEmpagliflozin | 98 | $70,622 |
| FarxigaDapagliflozin Propanediol | 38 | $40,785 |
| Repatha SureclickEvolocumab | 40 | $26,842 |
| CorlanorIvabradine Hcl | 13 | $9,897 |
| BrilintaTicagrelor | 13 | $5,759 |
| Flecainide Acetate | 137 | $2,952 |
| Rosuvastatin Calcium | 161 | $2,331 |
| Atorvastatin Calcium | 244 | $2,267 |
| Metoprolol Succinate | 340 | $2,255 |
| Ezetimibe | 131 | $2,049 |
| Amiodarone Hcl | 181 | $1,741 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 144 | $1,444 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $199 | $414,839516 claims |
| NovartisEntresto | $200 | $202,634240 claims |
| Johnson & JohnsonXarelto | $662 | $159,362195 claims |
| Boehringer IngelheimJardiance | $309 | $70,62298 claims |
| AstraZenecaFarxiga, Brilinta | $966 | $46,54551 claims |
| AmgenCorlanor | $476 | $9,89713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 292 adult health providers in South Carolina.
Other adult health in Spartanburg
- Melissa McCarterSpartanburg$12K
- Crystal HumphriesSpartanburg$7K
- Amy ClintonSpartanburg$7K
- Marva ThomasSpartanburg$5K
- Dana BrightSpartanburg$5K
- Shareda YoungSpartanburg$4K
- Karen RobertsonGreenville$69K
- Christine FranzeseTega Cay$30K
- Jessica RiceGreenville$15K
- Michelle PriceCharleston$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.